Roche plan investing $50 Billion in U.S
Swiss pharmaceutical giant Roche announced on Tuesday that it would invest $50 billion in the US over the next five years
Quick overview
- Roche announced a $50 billion investment in the US over the next five years to enhance manufacturing capabilities and create over 12,000 jobs.
- The investment will strengthen facilities in Indiana, Pennsylvania, Massachusetts, and California, and establish new R&D sites focused on AI and various diseases.
- A new manufacturing facility will be built to support Roche's next-generation weight loss medicines, with plans to export more medications from the US than imported.
- This move comes amid concerns over potential new tariffs on pharmaceutical products from overseas.
Swiss pharmaceutical giant Roche announced on Tuesday that it would invest $50 billion in the US over the next five years. This comes amid worries about the potential effects of new White House tariffs on pharmaceutical products from overseas.
According to Roche, the investment will support new manufacturing capabilities in the United States and create over 12,000 jobs, 1,000 of which will be with the company. Roche has 25,000 employees in the world’s largest economy.
In addition to strengthening and expanding its manufacturing facilities in Indiana, Pennsylvania, Massachusetts, and California, the pharmaceutical behemoth will invest in establishing new, cutting-edge research and development (R&D) sites.
AI research will be conducted at a new R&D facility in Massachusetts, which will also serve as a center for studies on treatments for metabolism, kidney disease, and cardiovascular disease.
The funding package will also be used to construct a new manufacturing facility in an undisclosed location to support Roche’s “expanding portfolio of next-generation weight loss medicines,
Roche stated that it would export more medications from the US than it imports after the manufacturing capacity investments are completed.
Pharmaceutical companies have been rushing to increase their US presence, with President Donald Trump threatening to remove the pharmaceutical industry’s exemption from import duties.
- Check out our free forex signals
- Follow the top economic events on FX Leaders economic calendar
- Trade better, discover more Forex Trading Strategies
- Open a FREE Trading Account
Related Articles
Comments
Sidebar rates
Join 350 000+ traders receiving Free Trading Signals
Alerts
Rates
Calendar
Signals